Table 3.
Effects of LS, LSA, LSB, LSC, and LSD on urinary electrolyte Na+ (mmol/L) concentrations within 1, 2, 4, 6, and 24 h after oral administration.
| Group | 1 h | 2 h | 4 h | 6 h | 24 h |
|---|---|---|---|---|---|
| Control | 101.88 ± 7.77 | 100.38 ± 8.50 | 99.33 ± 9.33 | 100.18 ± 2.04 | 100.30 ± 3.87 |
| Furosemide | 59.75 ± 1.34∗∗ | 67.43 ± 8.02∗∗ | 84.65 ± 3.77∗ | 96.00 ± 5.53 | 111.80 ± 8.59∗ |
| LS-H | 111.80 ± 8.59 | 114.13 ± 8.26 | 117.45 ± 8.13∗ | 120.15 ± 7.29∗∗ | 119.80 ± 8.69∗∗ |
| LS-M | 101.55 ± 11.09 | 102.28 ± 9.82 | 107.48 ± 9.73 | 114.15 ± 11.83 | 120.68 ± 1.78∗∗ |
| LS-L | 118.20 ± 6.20∗ | 117.30 ± 7.47∗ | 116.58 ± 6.93∗ | 115.83 ± 6.51∗∗ | 108.20 ± 10.16 |
| LSA-H | 114.95 ± 18.99 | 116.13 ± 14.65 | 121.00 ± 17.08 | 125.00 ± 12.53 | 142.28 ± 18.97∗∗ |
| LSA-L | 75.98 ± 7.60∗ | 78.00 ± 4.45∗ | 91.18 ± 6.00 | 100.28 ± 6.75 | 121.70 ± 9.37∗∗ |
| LSB-H | 128.18 ± 2.54∗∗ | 124.05 ± 3.26∗∗ | 111.65 ± 5.31 | 107.83 ± 4.08∗ | 111.55 ± 4.57∗∗ |
| LSB-L | 115.78 ± 9.47 | 116.95 ± 17.14 | 109.33 ± 15.01 | 102.30 ± 11.55 | 91.00 ± 7.95 |
| LSC-H | 94.95 ± 4.84 | 94.90 ± 5.96 | 85.10 ± 7.54 | 83.05 ± 9.22∗ | 78.38 ± 8.23∗∗ |
| LSC-L | 114.73 ± 9.48 | 110.80 ± 7.39 | 111.38 ± 11.17 | 112.35 ± 6.18∗∗ | 126.13 ± 10.13∗∗ |
| LSD-H | 106.03 ± 7.42 | 98.60 ± 4.03 | 94.50 ± 3.89 | 88.10 ± 4.62∗∗ | 74.43 ± 7.09∗∗ |
| LSD-L | 115.55 ± 5.26∗ | 113.10 ± 4.52∗ | 107.33 ± 5.44 | 112.08 ± 2.39∗∗ | 118.63 ± 5.80∗∗ |
The values are reported as mean ± SD for 8 rats in each group. ∗P < 0.05 and ∗∗P < 0.01 compared to the control.